Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, AbCellera Biologics Inc (NASDAQ: ABCL) closed at $2.52 up 0.80% from its previous closing price of $2.50. In other words, the price has increased by $0.80 from its previous closing price. On the day, 1.31 million shares were traded. ABCL stock price reached its highest trading level at $2.55 during the session, while it also had its lowest trading level at $2.46.
Ratios:
For a deeper understanding of AbCellera Biologics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.96 and its Current Ratio is at 10.96. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
On February 22, 2024, The Benchmark Company Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $9.
On December 05, 2023, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $6.KeyBanc Capital Markets initiated its Overweight rating on December 05, 2023, with a $6 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABCL now has a Market Capitalization of 742558272 and an Enterprise Value of 138361824. For the stock, the TTM Price-to-Sale (P/S) ratio is 22.46 while its Price-to-Book (P/B) ratio in mrq is 0.67. Its current Enterprise Value per Revenue stands at 4.186 whereas that against EBITDA is -0.645.
Stock Price History:
Over the past 52 weeks, ABCL has reached a high of $6.05, while it has fallen to a 52-week low of $2.40. The 50-Day Moving Average of the stock is -11.48%, while the 200-Day Moving Average is calculated to be -39.49%.
Shares Statistics:
For the past three months, ABCL has traded an average of 1.82M shares per day and 2406100 over the past ten days. A total of 290.82M shares are outstanding, with a floating share count of 206.46M. Insiders hold about 29.93% of the company’s shares, while institutions hold 36.23% stake in the company. Shares short for ABCL as of 1723680000 were 18168144 with a Short Ratio of 9.97, compared to 1721001600 on 17765588. Therefore, it implies a Short% of Shares Outstanding of 18168144 and a Short% of Float of 8.01.
